Showing results (21-30 of 65) with videos related to
Sort By:
Pageof 7
Pharmacology & Therapeutics|April 11, 2025
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapyElena Crecca, Gianfranco Di Giuseppe, Claudia Camplone, et al.Frontiers in Immunology|October 18, 2023
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticitySilvia D'Amico, Patrizia Tempora, Paula Gragera, et al.Frontiers in Immunology|July 3, 2025
A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptorsPaolo Romania, Loredana Cifaldi, Paula Gragera, et al.Mutation Research|December 27, 2011
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesotheliomaOmbretta Melaiu, Alfonso Cristaudo, Erika Melissari, et al.Journal of Translational Medicine|June 26, 2026
Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypesVirginia Vigiano Benedetti, Federica Conte, Daniele Santoni, et al.Oncoimmunology|July 7, 2017
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastomaElisa Brandetti, Irene Veneziani, Ombretta Melaiu, et al.International Journal of Molecular Sciences|January 11, 2024
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell SurvivalChiara Focaccetti, Camilla Palumbo, Monica Benvenuto, et al.International Journal of Molecular Sciences|February 25, 2023
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical StudiesOmbretta Melaiu, Gianluca Vanni, Ilaria Portarena, et al.Fertility and Sterility|July 2, 2019
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosisMonica Cipollini, Stefano Luisi, Paola Piomboni, et al.Plos One|June 23, 2017
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesotheliomaOmbretta Melaiu, Justin Stebbing, Ylenia Lombardo, et al.Pageof 7